We are a science-led global healthcare company with a special purpose: to help people do more, feel better, live longer.
turnover in 2019
years of innovation
What we do
We aim to bring differentiated, high-quality and needed healthcare products to as many people as possible, with our 3 global businesses, scientific and technical know-how and talented people.
How we do it
Everyone at GSK is focused on 3 priorities – Innovation, Performance, Trust
We invest in scientific and technical excellence to develop and launch a pipeline of new products that meet the needs of patients, payers and consumers.
adjusted R&D investment in 2019
new medicines in development at Q2 2020
new vaccines in development at Q2 2020
We aim to achieve industry-leading growth by investing effectively in our business, developing our people and delivering flawlessly.
turnover in 2019
adjusted operating profit in 2019
free cash flow in 2019
dividends paid in 2019
We are a responsible company and commit to use our science and technology to address health needs, make our products affordable and available and to be a modern employer.
employee engagement score on our latest employee survey
donated in 2019 to community health programmes
in Access to Medicines Index since the assessment began in 2008
Please refer to our quarterly results materials for further information on GSK’s financial performance.
US (+12% CER) sales turnover 2019
Europe (+2% CER) sales turnover 2019
International (+9% CER) sales turnover 2019
Find out more about us
Discover our latest financial performance announcement and search for historical quarterly results materials
Speeches & presentations
Search through our archive of speeches and presentations from conferences and events
It began when Plough Court Pharmacy was established in 1715. Discover GSK's journey through the centuries that led to the organisation we know today
We invest in scientific and technical excellence to develop and launch a pipeline of new products that meet the needs of patients and payers